329 related articles for article (PubMed ID: 12767492)
1. Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study.
Elwan O; Madkour O; Elwan F; Mostafa M; Abbas Helmy A; Abdel-Naseer M; Abdel Shafy S; El Faiuomy N
J Neurol Sci; 2003 Jul; 211(1-2):15-22. PubMed ID: 12767492
[TBL] [Abstract][Full Text] [Related]
2. Brain aging in normal Egyptians: neuropsychological, electrophysiological and cranial tomographic assessment.
Elwan O; Hassan AA; Abdel Naseer M; Fahmy M; Elwan F; Abel Kader A; Mahfouz M
J Neurol Sci; 1996 Mar; 136(1-2):73-80. PubMed ID: 8815182
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
[TBL] [Abstract][Full Text] [Related]
4. Impact of Personality on Cognitive Aging: A Prospective Cohort Study.
Caselli RJ; Dueck AC; Locke DE; Henslin BR; Johnson TA; Woodruff BK; Hoffman-Snyder C; Geda YE
J Int Neuropsychol Soc; 2016 Aug; 22(7):765-76. PubMed ID: 27346168
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.
Bartrés-Faz D; Junqué C; López-Alomar A; Valveny N; Moral P; Casamayor R; Salido A; Bel C; Clemente IC
J Am Geriatr Soc; 2001 Jul; 49(7):985-90. PubMed ID: 11527492
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.
Sapkota S; Wiebe SA; Small BJ; Dixon RA
Int J Geriatr Psychiatry; 2016 May; 31(5):502-9. PubMed ID: 26343804
[TBL] [Abstract][Full Text] [Related]
7. Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking.
Elwan O; Hassan AA; Abdel Naseer M; Elwan F; Deif R; El Serafy O; El Banhawy E; El Fatatry M
J Neurol Sci; 1997 May; 148(1):79-86. PubMed ID: 9125393
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment.
Bartrés-Faz D; Junqué C; Moral P; López-Alomar A; Sánchez-Aldeguer J; Clemente IC
J Neuropsychiatry Clin Neurosci; 2002; 14(1):80-3. PubMed ID: 11884660
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
10. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
11. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
12. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
[TBL] [Abstract][Full Text] [Related]
14. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
[TBL] [Abstract][Full Text] [Related]
15. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
16. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
Tautvydaitė D; Kukreja D; Antonietti JP; Henry H; von Gunten A; Popp J
Alzheimers Res Ther; 2017 Feb; 9(1):6. PubMed ID: 28153054
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores.
Bondi MW; Houston WS; Salmon DP; Corey-Bloom J; Katzman R; Thal LJ; Delis DC
J Int Neuropsychol Soc; 2003 Jul; 9(5):783-95. PubMed ID: 12901784
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
19. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
[TBL] [Abstract][Full Text] [Related]
20. Five-factor model personality traits and cognitive function in five domains in older adulthood.
Sutin AR; Stephan Y; Luchetti M; Terracciano A
BMC Geriatr; 2019 Dec; 19(1):343. PubMed ID: 31805866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
